Adjuvant Perjeta/pertuzumab

[mburkhart]

I was given neoadjuvant Perjeta starting in January 2015. I was Stage 2b, Grade 3, with one lymph node known to be involved. My chemo was TCHP, six rounds. I finished in May and had a bilateral mastectomy in June with one of nine nodes positive; which an earlier biopsy had already shown. It had greatly reduced the size of the tumor in my breast and the one in my lymph node although I did not have a" complete" response. I am now completing my year of just Herceptin. There was no question from the very beginning that Perjeta would be a part of my chemo and fully covered by my insurance. I had the option for neoadjuvant or adjuvant chemo and it would be the same simply because I am Her2 positive. It was not based on the lymph node involvement.